TB is the deadliest infectious diseases globally, with 10.8 million new cases and 1.25 million deaths in 2023. Effective screening for TB is an important intervention to quickly detect the disease ...

Speaking at the first day of the World Health Summit (WHS) Regional Meeting during the panel discussion Asia Region TB Vaccine R&D Financing, Dr. Swaminathan emphasised that an effective TB ...

TB Alliance's third licensed manufacturer makes pretomanid available through the Global Drug Facility, further improving affordability and access TB Alliance applauds a new milestone in the fight ...

The subject of Aldridge’s research is the bacterium Mycobacterium tuberculosis, the causative agent of tuberculosis. In 2023, TB made 10.8 million people sick and killed around 1.25 million people.

Pakistan's longstanding battle with tuberculosis (TB) has taken a dire turn, with the country now ranking fifth globally in the number of TB cases and fourth in drug-resistant TB. In Sindh ...

Simultaneously screening for both active and dormant TB infection could save lives, curtail infection rates, and rewrite the story of the continued spread of this disease. Researchers hope that this ...

Universidad Carlos III de Madrid (UC3M) has presented three scientific research projects contributing to the fight against tuberculosis, the leading cause of death from infectious disease in the ...

TB is the deadliest infectious diseases globally, with 10.8 million new cases and 1.25 million deaths in 2023. Effective screening is an important intervention to prevent its spread. TB can remain ...

“Through close collaboration with manufacturers, we have addressed critical unmet needs by developing practical solutions that make available and effective drug-resistant TB treatments not only ...